Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.6 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |